Mersana Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
05/15/2025 | 12.07 M | $4.15 B | 100.00% | 9.77% | |
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 05/15/2025 | 8.66 M | $2.98 M | 0.00% | 7.07% |
VANGUARD GROUP INC | 05/09/2025 | 8.38 M | $2.88 M | 18.71% | 6.78% |
BLACKROCK, INC. | 05/02/2025 | 8.33 M | $2.87 M | -9.55% | 6.74% |
SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 7.61 M | $2.62 M | 259.22% | 6.16% |
AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 5.14 M | $1.77 M | 100.00% | 4.16% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2025 | 3.81 M | $1.31 M | 11.16% | 3.11% |
VR ADVISER, LLC | 05/15/2025 | 3.57 M | $1.23 M | -65.16% | 2.92% |
SILVERARC CAPITAL MANAGEMENT, LLC | 05/14/2025 | 3.09 M | $1.06 M | 100.00% | 2.52% |
ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 2.99 M | $1.03 M | 100.00% | 2.42% |
STATE STREET CORP | 05/15/2025 | 2.60 M | $896.25 K | -5.82% | 2.11% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 2.44 M | $840.78 K | 0.00% | 1.98% |
05/15/2025 | 1.71 M | $586.87 K | 0.00% | 1.39% | |
683 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 1.65 M | $567.93 K | 83.33% | 1.34% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2025 | 1.33 M | $458.86 K | 19.89% | 1.08% |
5AM VENTURE MANAGEMENT, LLC | 05/15/2025 | 1.31 M | $449.18 K | 0.00% | 1.07% |
QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 1.17 M | $404.30 K | 238.10% | 0.95% |
NORTHERN TRUST CORP | 05/13/2025 | 864.79 K | $297.66 K | -6.98% | 0.70% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 839.92 K | $289.10 K | 38.54% | 0.68% |
DEUTSCHE BANK AG\ | 05/09/2025 | 839.72 K | $285.51 K | 0.00% | 0.68% |
IEQ CAPITAL, LLC | 05/14/2025 | 707.02 K | $243.36 K | 100.00% | 0.57% |
LION POINT CAPITAL, LP | 05/15/2025 | 644.00 K | $221.67 K | 100.00% | 0.53% |
05/15/2025 | 604.21 K | $207.85 K | 100.00% | 0.49% | |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 586.66 K | $201.93 K | -26.88% | 0.47% |
WOODLINE PARTNERS LP | 05/15/2025 | 435.59 K | $149.93 K | 0.00% | 0.35% |
PANAGORA ASSET MANAGEMENT INC | 05/15/2025 | 370.45 K | $127.51 K | 54.56% | 0.30% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 346.19 K | $119.16 K | 0.00% | 0.28% |
UBS GROUP AG | 05/13/2025 | 319.81 K | $110.01 K | 97.09% | 0.26% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 314.37 K | $108.14 K | -67.05% | 0.25% |
MORGAN STANLEY | 05/15/2025 | 307.13 K | $105.72 K | -74.48% | 0.25% |
STATE OF WYOMING | 05/14/2025 | 295.50 K | $101.71 K | 100.00% | 0.24% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 280.63 K | $96.59 K | -10.23% | 0.23% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 258.20 K | $88.87 K | -42.37% | 0.21% |
CERITY PARTNERS LLC | 04/30/2025 | 244.24 K | $84.07 K | 100.00% | 0.20% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 241.07 K | $82.98 K | 383.57% | 0.20% |
05/12/2025 | 232.22 K | $79.93 K | 100.00% | 0.19% | |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 201.45 K | $69.34 K | -44.22% | 0.16% |
ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 186.06 K | $64.04 K | 0.00% | 0.15% |
CWM, LLC | 05/01/2025 | 184.83 K | $64.00 K | 100.00% | 0.15% |
FMR LLC | 05/12/2025 | 171.08 K | $58.89 K | -42.84% | 0.14% |
RHUMBLINE ADVISERS | 05/29/2025 | 154.16 K | $53.02 K | -10.30% | 0.12% |
MACQUARIE GROUP LTD | 05/15/2025 | 150.00 K | $52.00 K | 0.00% | 0.12% |
ALGERT GLOBAL LLC | 05/13/2025 | 135.01 K | $46.00 K | 124.71% | 0.11% |
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 04/16/2025 | 130.70 K | $44.98 K | 100.00% | 0.11% |
BARCLAYS PLC | 05/15/2025 | 121.73 K | $41.00 K | -33.38% | 0.10% |
INVESCO LTD. | 05/12/2025 | 114.86 K | $39.54 K | 109.33% | 0.09% |
SAVANT CAPITAL, LLC | 05/08/2025 | 111.14 K | $38.26 K | 100.00% | 0.09% |
UBS OCONNOR LLC | 05/15/2025 | 97.73 K | $33.62 K | -76.16% | 0.08% |
PALLAS CAPITAL ADVISORS LLC | 04/14/2025 | 94.53 K | $32.54 K | 100.00% | 0.08% |
INTECH INVESTMENT MANAGEMENT LLC | 05/20/2025 | 90.36 K | $31.10 K | 77.08% | 0.07% |
Mersana Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 175 institutional investors and hedge funds held shares of Mersana Therapeutics, Inc.. The most heavily invested institutionals were:
Bain Capital Life Sciences Investors, LLC: 8.66 M
VANGUARD GROUP INC: 8.38 M
BlackRock, Inc.: 8.33 M
Schonfeld Strategic Advisors LLC: 7.61 M
AQR CAPITAL MANAGEMENT LLC: 5.14 M
Rock Springs Capital Management LP: 3.81 M
71.18% of Mersana Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 102.63 M shares in the last 24 months. This purchase volume represents approximately $29.71 M in transactions.